Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

New melanoma drug gives 63 percent reduction in risk of death compared to dacarbazine

Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center
New melanoma drug gives 63 percent reduction in risk of death compared to dacarbazine ( Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center )
17 Jun 2011

Exemestane significantly reduces risk of invasive breast cancer in high-risk, postmenopausal women

Dr Paul Goss - Dana-Farber/Harvard Cancer Center, Massachusetts General Hospital, Boston, USA
Exemestane significantly reduces risk of invasive breast cancer in high-risk, postmenopausal women ( Dr Paul Goss - Dana-Farber/Harvard Cancer Center, Massachusetts General Hospital, Boston, USA )
17 Jun 2011

Ipilimumab improves survival in metastatic melanoma

Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Ipilimumab improves survival in metastatic melanoma ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
17 Jun 2011

High dose chemotherapy helps combat neuroblastoma

Prof Ruth Ladenstein - University of Vienna, Austria
High dose chemotherapy helps combat neuroblastoma ( Prof Ruth Ladenstein - University of Vienna, Austria )
17 Jun 2011

Future for immunotherapies

Prof Angus Dalgleish - St George’s University, London, UK
Future for immunotherapies ( Prof Angus Dalgleish - St George’s University, London, UK )
17 Jun 2011

Highlights from 2011 and ASCO’s future

Prof George Sledge - Indiana University, USA
Highlights from 2011 and ASCO’s future ( Prof George Sledge - Indiana University, USA )
17 Jun 2011

ASCO 2011 highlights

Prof Gordon McVie – ecancer Managing Editor
ASCO 2011 highlights ( Prof Gordon McVie – ecancer Managing Editor )
16 Jun 2011

Susan G. Komen for the Cure; worldwide breast cancer advocacy

Liz Thompson - Susan G. Komen for the Cure, USA
Susan G. Komen for the Cure; worldwide breast cancer advocacy ( Liz Thompson - Susan G. Komen for the Cure, USA )
16 Jun 2011

Autologous stem cell transplantation

Dr Rob Coppes – University Medical Center Groningen, The Netherlands
Autologous stem cell transplantation ( Dr Rob Coppes – University Medical Center Groningen, The Netherlands )
14 Jun 2011

Advanced biological imaging technology

Dr Daniel Zips – Technical University, Dresden, Germany
Advanced biological imaging technology ( Dr Daniel Zips – Technical University, Dresden, Germany )
13 Jun 2011

Heterogeneity of tumours influences treatment

Prof Philippe Lambin, Maastricht University, The Netherlands
Heterogeneity of tumours influences treatment ( Prof Philippe Lambin, Maastricht University, The Netherlands )
13 Jun 2011

Multiple Myeloma: New Rescue Options For Patients After Front-Line Therapy

Dr Paul Richardson - Dana Farber Institute, Boston, USA
Multiple Myeloma: New Rescue Options For Patients After Front-Line Therapy ( Dr Paul Richardson - Dana Farber Institute, Boston, USA )
11 Jun 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation